Life Sciences Commons^™

Amikacin: Clinical And Laboratory Studies, Erwin J. Haas, T. Madhavan, Evelyn J. Fisher, Frank Cox, Keith Burch, Edward L. Quinn, Richard D. Nichols

Henry Ford Hospital Medical Journal

Amikacin was evaluated in vitro against S aureus and a variety of gram negative bacilli. In concentrations of 12.5 μg/ml or less, it suppressed the growth of all organisms except 15% of Proteus mirabilis. Peak serum levels in patients, following a 7.5 mg/kg IM dose, averaged 21 μg/ml at one hour. Most of the drug appeared in the urine during the first six hours after administration. Of six patients receiving an adequate course of treatment, all but one were cured. Treatment in that patient also failed with a subsequent course of gentamicin and carbenicillin and he was cured only by …